 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
CEPHALON INC, (CEPH) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Cephalon, Inc., a biopharmaceutical company, engages in the discovery, development, and marketing of products to treat sleep disorders, neurological disorders, cancer, and pain primarily in the United States. The company, through its wholly-owned subsidiary, CIMA LABS INC., also develops and manufactures orally disintegrating tablets using proprietary technologies. It markets three proprietary products, including Provigil for treating of excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome and shift work sleep disorder; Actiq for treating pain in opiod-tolerant cancer patients; and Gabitril, which is used as an adjunct therapy for treatment of partial seizures associated with epilepsy. The company sells its products primarily in North America and Europe. Cephalon was founded by Frank Baldino, Jr. and is headquartered in West Chester, Pennsylvania.
|
CEPHALON INC Related |
|
Cephalon Develops and markets products to treat and manage neurological disorders, sleep disorders, cancer, pain, and addiction.
|
|
Cephalon | Careers Cephalon ranked 26th in the listing of America's Top 100 employers with the best ... Copyright 2008. Cephalon, Inc. All Rights Reserved. Terms of Use. Privacy ...
|
|
Cephalon - Wikipedia, the free encyclopedia http://www.cephalon.com. Cephalon, Inc. ... Cephalon later successfully negotiated ... Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. ...
|
|
|
|
|
